Skip to content
Screener

Veracyte VCYT Q2 2025 earnings

Reported August 6, 2025 · After market close

Revenue$130.2MBeat by $5.8M
EPS$0.44Beat by $0.13
Revenue estimate$124.4M
EPS estimate$0.31

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$147.2M
EPS estimate$0.43

Financials

Q2 2025

Income statement

See full
Revenue$130.2M+13.8%
Gross profit$89.8M+15.2%
Operating income-$5.3M-214%
Net income-$980.0K-117%
EPS (diluted)-$0.01-114%

Balance sheet

See full
Cash & equivalents$221.2M-6.7%
Total debt$50.6M+143%
Total equity$1.2B+7.8%
Total assets$1.3B+8.9%

Cash flow

See full
Operating cash flow$33.6M+13.6%
CapEx$1.3M-53.6%
Free cash flow$32.3M+20.6%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$2.11B+29.9%
Enterprise value$1.93B+37.8%
P/E79.9×—
P/S4.4×+0.3×

Profitability

See full
Gross margin68.3%+2.5pp
Operating margin2.9%+1.6pp
Net margin5.5%+3.2pp
FCF margin17.5%+7.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0×0.0×
Current ratio5.4×+1.0×

Segments

By segment

See full
Reportable Segment$130.2M+13.8%

By geography

See full
United States$124.1M+17.3%

By product

See full
Testing revenue$122.3M+14.3%

FAQ

When did Veracyte report Q2 2025 earnings?
Veracyte (VCYT) reported Q2 2025 earnings on August 6, 2025 after market close.
What were Veracyte's Q2 2025 revenue and EPS?
Veracyte reported revenue of $130.2M and eps of $0.44 for Q2 2025.
Did Veracyte beat estimates in Q2 2025?
Revenue beat the consensus estimate of $124.4M by $5.8M. EPS beat the consensus estimate of $0.31 by $0.13.
How did Veracyte's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 13.8% from $114.4M a year earlier and eps grew 46.7% from $0.30.
Where can I find Veracyte's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001384101-25-000106) and the 10-Q periodic report (0001384101-25-000110) directly on SEC EDGAR. The filing index links above go to sec.gov.